Phase II trial of bevacizumab and everolimus in patients with advanced renal ... - UroToday PDF Print
UroTodayTwo groups of patients with metastatic renal cell carcinoma were eligible for this study: those with no previous treatment with targeted agents and those

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129